Cultivated Meat

Orbillion Achieves Multicontinental Production Milestone for Cultivated Beef

Orbillion has achieved a notable step in the cultivated meat sector, announcing the production of its beef muscle cells at manufacturing facilities in North America, Europe, and Asia. The expansion marks a key development in scaling cultivated meat for global markets while addressing the challenges of cost and large-scale production.

“This achievement is revolutionary—not just for Orbillion, but for the future of food”

As part of its efforts to accelerate commercialization, Orbillion has appointed Dr. Thomas Beck to its Board of Directors. Dr. Beck brings over 30 years of expertise in food technology, having held prominent roles at Nestlé and DSM Nutritional Products. His experience is expected to guide Orbillion as it transitions to broader market readiness.

Dr. Patricia Bubner, CEO of Orbillion, explained, “This achievement is more than just another milestone—it’s proof of our vision to make sustainable cultivated meat accessible worldwide. And Dr. Beck’s strategic insight, combined with our innovative technology, positions us to overcome the final hurdles to commercial production and affordability.”

Orbillion
© Orbillion

Orbillion’s approach to cultivated meat sets it apart from many competitors in the field. The company uses proprietary computational tools and “bioware” to directly scale beef muscle and fat cells without requiring genetic modification or lengthy cell adaptation processes. This method has enabled the company to reduce development costs by millions of dollars and cut production timelines by over a year.

Addressing systemic challenges 

The production of cultivated meat remains a complex process, with many companies relying on techniques adapted from biopharmaceutical manufacturing. These methods often prove unsuitable for the high volumes and low costs required to transform the global food system.

Orbillion’s founders, drawing on their backgrounds in biopharmaceuticals, have reimagined these processes specifically for food production. This expertise underpins the company’s efforts to streamline production and make cultivated meat a viable alternative to traditional protein sources.

Orbillion
© Orbillion

Funding to drive innovation

Earlier this year, Orbillion secured venture capital funding to advance its predictive modeling technology, known as the “scale-up algorithm,” with the goal of bringing a product to market within the next year. While the product has yet to reach consumers, this achievement marks a critical step toward that objective.

Given the regulatory hurdles facing the cultivated meat industry, including state-level bans, widespread market availability remains uncertain. However, Orbillion’s focus on scaling production ensures the company is well-positioned to meet demand once regulatory approvals are in place.

Dr. Samet Yildirim, Orbillion’s Chief Technology Officer, said, “This achievement is revolutionary—not just for Orbillion, but for the future of food. Direct scaling of beef muscle and fat cells—the very building blocks of meat—without GMO, serum or expensive growth factors, allows us to deliver the most tasty, sustainable, and cost-effective cultivated meat the world has ever seen.”




>> Click here to go to Cultivated X where you will see a familiar layout and a focus solely on content regarding cellular agriculture, including fermentation-enabled products, and with more granular categories.

Share

Interviews